Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Atea Pharmaceuticals (AVIR) over the last 7 years, with Dec 2024 value amounting to $416,000.

  • Atea Pharmaceuticals' Depreciation & Amortization (CF) rose 1385.71% to $104,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $260,000, marking a year-over-year increase of 796.55%. This contributed to the annual value of $416,000 for FY2024, which is negligibly% changed negligibly from last year.
  • As of FY2024, Atea Pharmaceuticals' Depreciation & Amortization (CF) stood at $416,000, which was down 0.00% from $416,000 recorded in FY2023.
  • Over the past 5 years, Atea Pharmaceuticals' Depreciation & Amortization (CF) peaked at $416,000 during FY2023, and registered a low of $19,000 during FY2020.
  • In the last 3 years, Atea Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $416,000 in 2024 and averaged $364,000.
  • Data for Atea Pharmaceuticals' Depreciation & Amortization (CF) shows a peak YoY soared of 796.55% (in 2022) over the last 5 years.
  • Over the past 5 years, Atea Pharmaceuticals' Depreciation & Amortization (CF) (Yearly) stood at $19,000 in 2020, then surged by 52.63% to $29,000 in 2021, then soared by 796.55% to $260,000 in 2022, then skyrocketed by 60.00% to $416,000 in 2023, then remained steady at $416,000 in 2024.